Published:
Lilly Recognized as One of the World's Top Biopharmaceutical Employers
INDIANAPOLIS, Oct. 10 /PRNewswire-FirstCall/ -- Eli Lilly and Company
(NYSE: LLY) announced today that it has made the list of Top 20
biopharmaceutical employers, according to the prestigious peer-reviewed
journal Science. Science's 2008 survey polled nearly 4,000 employees from 500
employers in the biotechnology, biopharmaceutical, pharmaceutical and related
industries. This year Lilly ranks number 10 on the list, up one position from
last year's survey.
"At Lilly, our mission is to deliver innovative medicines for some of the
world's most urgent unmet medical needs," said Steven Paul, M.D., executive
vice president of science and technology, and president of Lilly Research
Laboratories. "Core to our pipeline performance is the robust research
environment here at Lilly, including excellence in both basic scientific and
clinical research. Our world-renowned scientific talent has allowed Lilly to
establish what we believe to be one of the best mid-stage pipelines in the
industry, including 50 unique medicines - an all-time high for the company."
The web-based survey aims to determine the most reputable employers in the
life science industries based on 23 characteristics, including among others,
treating employees with respect, financial strength, easy adaptation to
change, and a research-driven environment. The survey results appeared in
today's issue of Science.
"It is an honor for Lilly to be recognized as one of the industry's top
employers based on these important criteria," said John Lechleiter, Ph.D.,
Lilly president and chief executive officer. "Respect for people has always
been a core value of Eli Lilly and Company, and this acknowledgement
underscores Lilly's commitment to our employees and the patients we serve."
Approximately 25 percent of Lilly's 2007 sales came from biotech
medicines; this makes the biotech portion of the company's business the
equivalent of the world's fifth largest biotech company. Biotech molecules
also represent approximately one-third of the company's current pipeline
including potential treatments targeting Alzheimer's disease, cancer and
diabetes.
About Science
Published by the American Association for the Advancement of Science
(AAAS), Science ranks as the world's largest general science journal. Each
week, Science provides more than 130,000 global subscribers with peer-reviewed
original research, scientific research articles, science and research news and
more. Science also produces a freely accessible careers website,
ScienceCareers.org, offering thousands of job listings, career advice and
more.
About Lilly
Lilly, a leading innovation-driven corporation, is developing a growing
portfolio of first-in-class and best-in-class pharmaceutical products by
applying the latest research from its own worldwide laboratories and from
collaborations with eminent scientific organizations. Headquartered in
Indianapolis, Ind., Lilly provides answers - through medicines and information
- for some of the world's most urgent medical needs. Additional information
about Lilly is available at www.lilly.com.
C-LLY
SOURCE Eli Lilly and Company
Copyright © 2008, PRNewswire
Copyright © 2008, NewsBlaze,
Daily News
Tags: ,BIO,MTC,HEA,SVY,IN-Lilly-named-top
_ _Is your favorite bookmark site missing?
Ask for it.